We’re delighted to see that the NHS 10-Year Plan has now stated that the standard of care for skin cancer pathways will be powered by appropriately regulated AI by 2028.
But 2028 is not the start line, it's the finish line - change needs to begin now👇https://t.co/e9wCdG006B
Skin Analytics' CEO & founder, Neil Daly, recently gave evidence at the @CommonsSITC meeting following an invite from @kitmalthouse.
Neil spoke about risk asymmetry and how we think about technology vs the risk of doing nothing.
More here: https://t.co/Y17D6yD1qI
💬 "The doctor told me it was cancerous, and it had to go. I was absolutely stunned by a) the speed at which they had got that information and b) how quickly they got it to me. […] I’m a total convert [to using AI].”
💙 Read Clare’s story in @theipaper: https://t.co/wuaxgZrKaY
Thanks for all your questions to Skin Analytics CEO Neil Daly at #BAD2025 today! ☕❓
Topics ranged from clinical evidence & regulatory approval to DERM’s role in NHS pathways, health economics, integrations & more.
Still have a question? Catch the team at stand G7 tomorrow!
📍 #BAD2025 Day 2 – Stand G7!
Come chat with the team about world-leading skin cancer pathways using DERM.
⏳ At 1:15pm, our CEO Neil Daly will be answering your questions live & unfiltered.
🎁 Grab a free mug + Costa voucher.
📩 Submit your question https://t.co/qi7jgTIwwE
👋🏼 We're at #BAD2025
❓Ask our CEO, Neil Daly, anything:
🕥 Wednesday 2nd July | 1:15pm
📍 Skin Analytics stand (G7)
👕 Look for the “Curious or Cautious?” tees
📩 Submit your question (anon or not!): https://t.co/qi7jgTHYH6
#BADAnnualMeeting
💬If you could ask our CEO anything, what would it be?
Submit a question (anon or not) & grab a mug + Costa voucher at #BAD2025:
https://t.co/qi7jgTHYH6
🗓️ Wed 2 July | 1:15pm 📍 Skin Analytics stand G7 👕 Look out for the “Curious or Cautious?” tees
#BADAnnualMeeting
Congratulations to our teledermatology team who won the Digital Clinical Safety Award
@HSJ_Awards.
Since 2022, our partnership with @SkinAnalytics
has safely used AI to discharge 2,600+ patients, avoiding 95% of urgent F2F appointments & freeing up dermatology capacity. 👏
🎉 We were proud to present the ‘AI Company of the Year’ award to @SkinAnalytics at the @BritDataAwards 2025 last night - congratulations to all the finalists and the winner 🏆
A huge thank you to @PredatechSec for hosting such an inspiring evening.
📢🚨 NICE recommends DERM for autonomous use across the NHS 🚨📢
This marks a major milestone in the use of AI for NHS dermatology: https://t.co/VIc4xqMtTo
@NICEComms
Investment News
@SkinAnalytics secures £15 million Series B Investment led by Intrepid Growth Partners
Congratulations to Neil Daly, Mark Machin the team on the investment!
Full press release here: https://t.co/8Ls3ZpRTlH
#UKTechInvestmentNews#Investment#Deallite#SeriesB
Skin Analytics – the British healthtech company on a mission to build a future where nobody dies of skin cancer – has secured £15 million in Series B funding.
@SkinAnalytics
https://t.co/DOWEijWQlJ
#SkinAnalytics#news#startup#funding
@SkinAnalytics , a pioneering British health technology company, has announced a successful £15m Series B funding round. Mission success – the company now has the facilities it needs to carry out…
#business#healthcare#news#uk#cancer#thetruant
https://t.co/34l1pYbPuk
Across Suffolk & NE Essex ICB, primary and secondary care orgs partnered to deploy @SkinAnalytics ' AI (DERM) to improve skin cancer detection and referrals. Join our webinar to see the impact of NHS-AIaMD collaboration in dermatology. https://t.co/SiTytc90vQ
📢 BREAKING @SkyNews📢
Skin Analytics raises £15 million, led by Intrepid Growth Partners, to fund growth plans and further help the fight against skin cancer.
https://t.co/Um3y6EEQTU
Register for our upcoming webinar, in association with @SkinAnalytics, taking place on April 29, on what’s possible when collaboration across NHS organisations and AI as a Medical Device for dermatology come together.
Sign up today: https://t.co/SiTytc90vQ